Tema Heart & Health ETF Rating $30.45 -0.24 (-0.78%) As of 03:49 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Heart & Health ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.73Holdings in HRTS have an aggregate rating of Moderate Buy based on 448 analyst ratings issued in the past year covering 21 companies (66.5% of the portfolio).HRTS Aggregate Price Target$30.45High Prediction$30.45Average Prediction$30.45Low Prediction$30.45Holdings in HRTS have an aggregate price target of $30.45 and a range of $30.45 to $30.45 covering 21 companies (66.5% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Heart & Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.05%LLYEli Lilly and Company$754.90-0.2%4.9979 of 5 stars2.70$950.17 25.9%23Trending News4.64%ABTAbbott Laboratories$133.92+1.0%4.8837 of 5 stars2.91$144.47 7.9%22Positive News4.56%UNHUnitedHealth Group$352.61-0.3%4.8857 of 5 stars2.52$358.95 1.8%25Trending NewsAnalyst ForecastOptions Volume4.27%RHHBYRoche$41.35-1.7%N/A2.5773.86%BSXBoston Scientific$102.71-1.6%4.793 of 5 stars3.08$118.04 14.9%26Trending NewsAnalyst ForecastAnalyst Revision3.50%ABBVAbbVie$218.40-0.8%4.7812 of 5 stars2.92$217.10 -0.6%26Trending NewsDividend AnnouncementAnalyst ForecastAnalyst Revision3.35%GILDGilead Sciences$114.55-2.8%4.9115 of 5 stars2.89$115.39 0.7%27Positive News3.32%TMOThermo Fisher Scientific$479.48-2.4%4.9749 of 5 stars2.77$592.24 23.5%22Trending NewsAnalyst UpgradeInsider TradeAnalyst Revision3.15%BBIOBridgeBio Pharma$51.21-2.6%4.4552 of 5 stars3.00$63.94 24.9%17Positive NewsAnalyst Forecast3.01%MDTMedtronic$94.05-0.2%4.9317 of 5 stars2.63$102.14 8.6%19Positive News2.62%CRNXCrinetics Pharmaceuticals$34.00+0.8%3.6943 of 5 stars2.78$68.86 102.5%9Positive News2.56%VRTXVertex Pharmaceuticals$394.53-0.7%4.9087 of 5 stars2.57$496.05 25.7%28News CoveragePositive NewsAnalyst Forecast2.48%MRKMerck & Co., Inc.$82.87-2.7%4.9965 of 5 stars2.35$107.44 29.6%20Positive News2.44%ALNYAlnylam Pharmaceuticals$465.89-0.6%3.7963 of 5 stars2.85$421.28 -9.6%27Positive NewsAnalyst ForecastInsider Trade2.43%AMGNAmgen$276.39-2.2%4.6348 of 5 stars2.32$304.43 10.1%22Positive News2.32%DHRDanaher$190.07-2.6%4.993 of 5 stars2.85$246.35 29.6%20News CoveragePositive NewsDividend Announcement2.16%EWEdwards Lifesciences$77.50-0.7%4.6962 of 5 stars2.67$86.26 11.3%24Positive NewsShort Interest ↑2.14%REGNRegeneron Pharmaceuticals$560.00-1.4%4.7617 of 5 stars2.82$817.67 46.0%28Positive NewsShort Interest ↑1.99%BMYBristol Myers Squibb$46.22-2.8%4.869 of 5 stars2.24$56.38 22.0%21Positive News1.80%MCKMcKesson$711.32-1.2%4.5471 of 5 stars2.85$725.10 1.9%13News CoveragePositive News1.80%DXCMDexCom$76.22+0.3%4.9498 of 5 stars2.91$99.89 31.1%22 This page (NASDAQ:HRTS) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Heart & Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Heart & Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTS Stock Alerts